Drug Information

Drug General Information
Drug ID
D08CMW
Former ID
DNC012193
Drug Name
6-Phenylaminomethyl-quinazoline-2,4-diamine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [526679]
Formula
C15H15N5
Canonical SMILES
C1=CC=C(C=C1)NCC2=CC3=C(C=C2)N=C(N=C3N)N
InChI
1S/C15H15N5/c16-14-12-8-10(6-7-13(12)19-15(17)20-14)9-18-11-4-2-1-3-5-11/h1-8,18H,9H2,(H4,16,17,19,20)
InChIKey
SQHNSLWKFCXHKZ-UHFFFAOYSA-N
PubChem Compound ID
487412
Target and Pathway
Target(s) Dihydrofolate reductase Target Info Inhibitor [526679]
PathWhiz Pathway Folate Metabolism
Pterine Biosynthesis
Reactome E2F mediated regulation of DNA replication
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
Metabolism of folate and pterines
G1/S-Specific Transcription
References
Ref 526679J Med Chem. 2003 Jul 31;46(16):3455-62.Design and synthesis of dihydrofolate reductase inhibitors encompassing a bridging ester group. Evaluation in a mouse colitis model.
Ref 526679J Med Chem. 2003 Jul 31;46(16):3455-62.Design and synthesis of dihydrofolate reductase inhibitors encompassing a bridging ester group. Evaluation in a mouse colitis model.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.